Prediction of Clinically Relevant Safety Signals of Nephrotoxicity through Plasma Metabolite Profiling
Addressing safety concerns such as drug-induced kidney injury (DIKI) early in the drug pharmaceutical development process ensures both patient safety and efficient clinical development. We describe a unique adjunct to standard safety assessment wherein the metabolite profile of treated animals is co...
Main Authors: | W. B. Mattes, H. G. Kamp, E. Fabian, M. Herold, G. Krennrich, R. Looser, W. Mellert, A. Prokoudine, V. Strauss, B. van Ravenzwaay, T. Walk, H. Naraoka, K. Omura, I. Schuppe-Koistinen, S. Nadanaciva, E. D. Bush, N. Moeller, P. Ruiz-Noppinger, S. P. Piccoli |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2013/202497 |
Similar Items
-
Species differences in methotrexate-induced hepatotoxicity and nephrotoxicity: Rabbits resist methotrexate nephrotoxicity
by: Jawad H. Ahmed
Published: (2016-06-01) -
Effect of Different Dosage Frequency of Polymyxin B on Rat Nephrotoxicity
by: Sun W, et al.
Published: (2021-02-01) -
The right bug in the right place: opportunities for bacterial vaginosis treatment
by: Du, J., et al.
Published: (2022) -
Nephrotoxicity of HAART
by: Robert Kalyesubula, et al.
Published: (2011-01-01) -
Nephrotoxic characteristics of anti-tuberculosis drugs
by: G. N. Mozhokina, et al.
Published: (2019-11-01)